Best of ASTRO® 2024: Best in Breast – Dr. Jeffrey Cao
OR
Chair
Dr. Paris-Ann Ingledew
Dr. Joanne Alfieri
Panelists
Dr. Jeffrey Cao
Studies/trials discussed:
- EARLY Results off the French Multicenter,, Randomized SHARE Trial comparing whole Breast Irradiation V Accelerated Partial Breast Irradiation in PostMenopausal women ith early stage Breast cancer
- Partial breast radiotherapy for women with early breast cancer: 10 year outcomes from IMPORT LOW (CRUK/06/003)
- Interim Result of Phase 1 study of Ablative Preoperative single fraction stereootactic artial Breast Irradiation (S-PBI) for Early Stage Breast Cancer
- Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer
- Stereotactic Ablative Body Radiotherapy (SABR) for Oligoprogressive ER+ HER2Breast Cancer
- Postmastectomy Radiation with Proton Beams Increases Risk of Capsular Contracture and Reconstruction Failure compared to Photons: Inverse ProbabilityWeighted Comparative Effectiveness Analysis
- Patient-Reported and Toxicity Results from the
- FABREC Study: A Multicenter Randomized Trial of Hypofractionated versus
- Conventionally-Fractionated Postmastectomy
- Radiation Therapy After Implant-Based Reconstruction
